Inovigate
Ingrid Maes is a seasoned executive in the pharmaceutical, life sciences, and healthcare sectors, currently serving as Managing Director and Founder of Inovigate, a consultancy dedicated to addressing financial and strategic challenges for clients. Ingrid also holds the position of Chief Executive Officer at CuratyHealth, a digital medicine platform aimed at improving patient outcomes through personalized medicine. Additional roles include Entrepreneur In Residence at Vlerick Business School and a former Co-Founder of H2M - Health to Market. Ingrid has extensive experience in investment advising as a member of the Investment Committee for the Caring Entrepreneurship Fund at the King Baudouin Foundation and has directed programs focused on business innovation in health. Prior positions include management consultancy roles at IM C&C and PricewaterhouseCoopers, and key consulting and business development roles at Siemens and Bran+Luebbe. Ingrid's academic background includes a Master in Engineering Sciences, specializing in Biotechnology and Genetic Engineering from Vrije Universiteit Brussel.
This person is not in any teams
Inovigate
Inovigate’s mission is to help our clients to innovate and successfully navigate through an increasingly complex and converging health ecosystem with the ultimate goal of improving health outcomes. We offer management consulting services and solutions for life sciences, medical technology and healthcare organisations. Our focus is on optimising strategies, business models, organisations and processes. We pride ourselves on our ability to initiate and invest in outcomes-based ventures that encourage future talent of the future to bring innovations out of the lab and into the market.